Inflammatory biomarkers and risk of lung cancer

Journal of the National Cancer Institute

Volumn 103, Issue 14, 2011, Pages 1073-1075

  Lagiou, Pagona ^a,b   Trichopoulos, Dimitrios ^b,c  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c BIOMEDICAL RESEARCH FOUNDATION   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; INTERLEUKIN 6; INTERLEUKIN 8;

CANCER GROWTH; CANCER RISK; CANCER SCREENING; CANCER STAGING; CHRONIC INFLAMMATION; DISEASE ASSOCIATION; DISEASE MARKER; EDITORIAL; HUMAN; LUNG CANCER; PATHOGENESIS; PRIORITY JOURNAL; SMOKING CESSATION; SMOKING HABIT;

C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; HUMANS; INFLAMMATION; INTERLEUKIN-6; INTERLEUKIN-8; LUNG NEOPLASMS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; RESEARCH DESIGN; RISK ASSESSMENT; RISK FACTORS; SMOKING; SMOKING CESSATION; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL; UNITED STATES;

EID: 79960709061     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djr220     Document Type: Editorial

References (17)

1. Ried T. Homage to Theodor Boveri (1862-1915): Boveri's theory of cancer as a disease of the chromosomes, and the landscape of genomic imbalances in human carcinomas. Environ Mol Mutagen. 2009;50(8):593-601.
2. Stuver S, Trichopoulos D. Cancer of the liver and biliary tract. In Adami HO, Hunter D, Trichopoulos D, eds. Textbook of Cancer Epidemiology. 2nd ed. New York, NY: Oxford University Press; 2008:317-322.
3. Ylitalo N, Stuver S, Adami HO. Cervical cancer. In: Adami HO, Hunter D, Trichopoulos D, eds. Textbook of Cancer Epidemiology. 2nd ed. New York, NY: Oxford University Press; 2008:453-460.
4. Siemes C, Visser LE, Coebergh JW, et al. C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study. J Clin Oncol. 2006;24(33):5216-5222. (Pubitemid 46631365)
5. Heikkila K, Ebrahim S, Lawlor DA. A systematic review of the association between circulating concentrations of C reactive protein and cancer. J Epidemiol Community Health. 2007;61(9):824-833.
6. Chaturvedi AK, Caporaso NE, Katki HA, et al. C-reactive protein and risk of lung cancer. J Clin Oncol. 2010;28(16):2719-2726.
7. Takahashi H, Ogata H, Nishigaki R, Broide DH, Karin M. Tobacco smoke promotes lung tumorigenesis by triggering IKKbeta-and JNK1-dependent inflammation. Cancer Cell. 2010;17(1):89-97.
8. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140(6):883-899.
9. Yanagawa H, Sone S, Takahashi Y, et al. Serum levels of interleukin 6 in patients with lung cancer. Br J Cancer. 1995;71(5):1095-1098.
10. Orditura M, De Vita F, Catalano G, et al. Elevated serum levels of interleukin-8 in advanced non-small cell lung cancer patients: relationship with prognosis. J Interferon Cytokine Res. 2002;22(11):1129-1135. (Pubitemid 36051185)
11. Pine SR, Mechanic LE, Enewold L, et al. Increased levels of circulating interleukin-6, interleukin-8, C-reactive protein and risk of lung cancer. J Natl Cancer Inst. 2011;103(14):1112-1122.
12. Takizawa H, Tanaka M, Takami K, et al. Increased expression of inflammatory mediators in small-airway epithelium from tobacco smokers. Am J Physiol Lung Cell Mol Physiol. 2000;278(5):L906-L913. (Pubitemid 30351045)
13. Bermudez EA, Rifai N, Buring J, Manson JE, Ridker PM. Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arterioscler Thromb Vasc Biol. 2002;22(10):1668-1673.
14. Crook MA, Scott DA, Stapleton JA, Palmer RM, Wilson RF, Sutherland G. Circulating concentrations of C-reactive protein and total sialic acid in tobacco smokers remain unchanged following one year of validated smoking cessation. Eur J Clin Invest. 2000;30(10):861-865.
15. Kaminska J, Kowalska M, Kotowicz B, et al. Pretreatment serum levels of cytokines and cytokine receptors in patients with non-small cell lung cancer, and correlations with clinicopathological features and prognosis. M-CSF-an independent prognostic factor. Oncology. 2006;70(2):115-125. (Pubitemid 43760337)
16. Peto R, Darby S, Deo H, Silcocks P, Whitley E, Doll R. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ. 2000;321(7257):323-329. (Pubitemid 30496873)
17. Boyle P, Levin B. World Cancer Report 2008. Lyon, France: IARC Sci Publ; 2008.